Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Latest Articles
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • Topics
    • Applied and Environmental Science
    • Clinical Science and Epidemiology
    • Ecological and Evolutionary Science
    • Host-Microbe Biology
    • Molecular Biology and Physiology
    • Therapeutics and Prevention
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About mBio
    • Editor in Chief
    • Board of Editors
    • AAM Fellows
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
mBio
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Latest Articles
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • Topics
    • Applied and Environmental Science
    • Clinical Science and Epidemiology
    • Ecological and Evolutionary Science
    • Host-Microbe Biology
    • Molecular Biology and Physiology
    • Therapeutics and Prevention
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About mBio
    • Editor in Chief
    • Board of Editors
    • AAM Fellows
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
Research Article | Molecular Biology and Physiology

ORBIT: a New Paradigm for Genetic Engineering of Mycobacterial Chromosomes

Kenan C. Murphy, Samantha J. Nelson, Subhalaxmi Nambi, Kadamba Papavinasasundaram, Christina E. Baer, Christopher M. Sassetti
Carol A. Nacy, Editor
Kenan C. Murphy
aDepartment of Microbiology and Physiological Systems, University of Massachusetts Medical School, Worcester, Massachusetts, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Samantha J. Nelson
aDepartment of Microbiology and Physiological Systems, University of Massachusetts Medical School, Worcester, Massachusetts, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Subhalaxmi Nambi
aDepartment of Microbiology and Physiological Systems, University of Massachusetts Medical School, Worcester, Massachusetts, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kadamba Papavinasasundaram
aDepartment of Microbiology and Physiological Systems, University of Massachusetts Medical School, Worcester, Massachusetts, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christina E. Baer
aDepartment of Microbiology and Physiological Systems, University of Massachusetts Medical School, Worcester, Massachusetts, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christopher M. Sassetti
aDepartment of Microbiology and Physiological Systems, University of Massachusetts Medical School, Worcester, Massachusetts, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carol A. Nacy
Sequella, Inc.
Roles: Editor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/mBio.01467-18
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Supplemental Material
  • FIG 1
    • Open in new tab
    • Download powerpoint
    FIG 1

    RecT-promoted oligonucleotide-mediated 60-base insertion. (a) Diagram of oligonucleotide-mediated recombineering of a chromosomal target in M. smegmatis. An integrating plasmid (pKM433) at the L5 phage attachment site contains a mutated hyg resistance gene due to an internal 60-bp deletion (red square). Electroporation of an oligonucleotide containing the 60 bases missing in the target gene, along with 60 bp of flanking DNA on each side, was electroporated into cells expressing the Che9c RecT function from pKM402. (b) After induction of RecT and preparation of the cells for transformation (as described in Materials and Methods), the cells were electroporated with various amounts of an oligonucleotide (180 mer) that spans the 60-bp deletion of the Hyg resistance cassette in pKM433. Cells were grown overnight in 7H9 broth, and half the culture volume was plated on LB-Hyg plates. The experiment was performed in triplicate; standard errors are shown.

  • FIG 2
    • Open in new tab
    • Download powerpoint
    FIG 2

    Plasmids constructed for ORBIT. (a) Construct pKM444 expresses the Che9c phage RecT annealase and the Bxb1 phage integrase, both driven from the Ptet promoter. A similar construct (pKM461) additionally contains the sacRB counter-selectable marker for curing the plasmid following gene modification. (b) One of the ORBIT payload plasmids (pKM446) used for integration into the chromosomal attP site created by an oligonucleotide. In this case, the plasmid payload contains a Flag-DAS+4 inducible degradation tag that is ultimately going to be fused to the 3′ end of the target gene. Camr, chloramphenicol resistance. (c) Three genes in M. smegmatis were targeted for C-terminal tagging. Following the ORBIT protocol for each target gene, the total numbers of colonies obtained (from multiple trials) ranged between 20 to 200 CFU/transformation. Electroporations performed with payload plasmid only (no targeting oligonucleotides) produced, on average, 5-fold-lower total numbers of colonies. The number of correct recombinants (of 4 candidates tested) for each target gene is shown. (d) PCR analysis of the 5′ junctions of each candidate tested. (e) Primer positions for verification by PCR of the recombinants are shown. Blue arrows, 5′ junction; brown arrows, 3′ junction. In each case where a 5′ junction was verified, the 3′ junction was also verified (not shown). The 5′ junctions were confirmed by DNA sequencing.

  • FIG 3
    • Open in new tab
    • Download powerpoint
    FIG 3

    Knockdown phenotypes of ORBIT-generated DAS+4-tagged strains. The growth phenotypes of the Flag-DAS+4 tagged strains constructed as described in the Fig. 2 legend were analyzed after transformation of an SspB-expressing plasmid. (a) The recA–Flag-DAS+4 strain was transformed with an SspB-producing plasmid, pGMCgS-TetON-18 (streptomycin resistance [Strepr]), under the control of the reverse TetR repressor. In this scenario, RecA is degraded in the absence of anhydrotetracycline (ATc). Ten-fold serial dilutions of the cells grown overnight without ATc were spotted on LB-streptomycin plates, either with or without ATc, and the cells were exposed to 20 J/m2 of UV. Preferential UV sensitivity of the recA–Flag-DAS+4 strain in the absence of ATc was determined by comparing the levels of growth seen with and without the inducer. (b) The divIVA–Flag-DAS+4 strain was transformed with an SspB-producing plasmid, pGMCgS-TetOFF-18 (Strepr), under the control of the wild-type TetR repressor. In this case, DivIVA is expected to be depleted in the presence of ATc. Preferential growth of the DivIVA–Flag-DAS+4 strain on LB plates in the presence of ATc was determined by comparing the levels of growth seen with and without the inducer. (c) The experiment was performed as described for panel B, except that leuB was the target and the cells were plated on 7H10-AD plates.

  • FIG 4
    • Open in new tab
    • Download powerpoint
    FIG 4

    ORBIT-promoted gene alteration. The ORBIT process is initiated at the replication fork. An oligomer containing a single-stranded version of the Bxb1 attP site (top pictures, red lines) is coelectroporated with an attB-containing nonreplicating plasmid into a mycobacterial host cell expressing both RecT annealase and Bxb1 integrase. RecT promotes annealing of the oligonucleotide to the lagging strand template. Following DNA replication through this region, an attP site is formed in the chromosome (middle pictures). In the same outgrowth period, Bxb1 integrase promotes site-specific insertion of the plasmid into the chromosome (attB × attP). (Left side) The oligonucleotide is designed such that attP is inserted just before the stop codon. The integration event fuses the GFP tag in frame to the 3′ end of the target gene (with an attL site in frame between them); the recombinant is selected for by Hygr. (Right side) The oligonucleotide is designed such that attP replaces the target gene and the plasmid integration event allows hygromycin resistance to be used to select for the knockout.

  • FIG 5
    • Open in new tab
    • Download powerpoint
    FIG 5

    Parameters of the ORBIT process. (A) The amount of target homology flanking the attP site in an oligonucleotide designed to create a polA–Flag-DAS+4 fusion in M. smegmatis was examined as a function of recombinant formation (Hygr). One microgram of each oligonucleotide was electroporated with 200 ng of pKM446. The frequency of targeting is expressed as the percentage of Hygr transformants following integration of pKM446 relative to a transformation control (20 ng of gentamicin resistance [Genr] plasmid pKM390). Experiments were performed in triplicate; standard errors are shown. Gent, gentamicin. (B) Colony counts were determined after electroporation of 1 μg of an oligonucleotide with 70-base flanks (designed to create a polA–Flag-DAS+4 fusion) with various amounts of pKM446. CFU counts per milliliter were determined following overnight growth of the electroporation mixtures in 2 ml LB. Experiments were performed in triplicate; standard errors are shown.

  • FIG 6
    • Open in new tab
    • Download powerpoint
    FIG 6

    ORBIT-generated insertions and deletions in M. tuberculosis and M. smegmatis. Gene deletions and modifications were performed at a variety of positions in the chromosomes of both M. tuberculosis (a) and M. smegmatis (b) using ORBIT. In most cases, the oligonucleotides contained an attP site flanked by 70 bases of target homology. Insertions (C-terminal DAS+4 or His-Flag tags) are shown in red, deletions are shown in blue, and GFP tags are shown in green. Descriptions of all the modifications performed by ORBIT are provided in Table 1 (for M. smegmatis) and Table 2 (for M. tuberculosis).

  • FIG 7
    • Open in new tab
    • Download powerpoint
    FIG 7

    ORBIT-generated GFP fusions. M. smegmatis cells containing GFP-tagged target genes were grown in 7H9-AD-Tween 80 to an optical density of 0.8. One microliter of the culture was spotted on an agarose pad for microscopy. Each bacterial strain was imaged using differential interference contrast (DIC) and GFP channels, as described in Material and Methods.

  • FIG 8
    • Open in new tab
    • Download powerpoint
    FIG 8

    Promoter replacements. (a) Diagram of ORBIT-generated promoter replacements. In the nonreplicating plasmid, the promoter to be inserted into the chromosome is placed to the left of the attB site. A TrrnB terminator is placed upstream of this promoter to prevent read-through from the plasmid backbone. The oligonucleotide is designed to place attP just upstream of the target gene in place of the endogenous promoter. Following integration, the promoter and inserted ribosome-binding site drive expression of the chromosomal target gene (lacZ). (b) ORBIT was carried out with plasmids pKM496 (PGroEL), pKM508 (Pimyc), and pKM509 (P38) with an oligonucleotide that deletes the endogenous promoter. Extracts of the cells were made, and beta-galactosidase assays were performed in triplicate (standard error bars are shown). The higher amounts of beta-galactosidase present in the engineered strains, relative to the starting strain, were likely due to the presence of the optimized ribosome-binding site following each promoter.

Tables

  • Figures
  • Supplemental Material
  • TABLE 1

    ORBIT-promoted M. smegmatis modifications

    GeneDesignationFunctionNo. of correct
    recombinants/total
    no. tested
    Flag-Das4 tags
        leuBMSMEG_23793-Isopropylmalate dehydrogenase2/4
        recAMSMEG_2723Recombinase4/4
        divIVAMSMEG_4217DivIVA protein3/4
        dnaNMSMEG_0001DNA polymerase III, beta subunit2/2
        dinBMSMEG_3172DNA gyrase2/2
        dnaKMSMEG_0709Chaperone (heat shock)1/2
        recDMSMEG_1325ExoV, α-subunit2/4
        recBMSMEG_1327ExoV, β-subunit2/2
        adnBMSMEG_1943ATP-dependent helicase/recombinase2/2
        recGMSMEG_2403ATP-dependent DNA helicase2/2
        ftsKMSMEG_2690DNA translocase3/6
        ruvAMSMEG_2944Holliday junction branch migration1/2
        ruvBMSMEG_2945Holliday junction branch migration3/4
        ruvCMSMEG_2943Holliday junction resolvase1/2
        priAMSMEG_3061Replication restart2/2
        polAMSMEG_3839DNA polymerase I4/6
        dinBMSMEG_3172DNA polymerase IV2/2
        fhaBMSMEG_0034FHA domain-containing protein6/12
        sepFMSMEG_4219Interaction with FtsZ and MurG1/2
        uvrD2MSMEG_1952ATP-dependent DNA helicase2/2
        nucSMSMEG_4493ssDNA-binding protein3/4
    GFP tags
        dnaNMSMEG_0001DNA polymerase III, beta subunitnra
        mmpL3MSMEG_0205MmpL family proteinnr
        sppAMSMEG_1476Signal peptide peptidasenr
        clpCMSMEG_6091ATP-dependent protease ATP-binding proteinnr
    MSMEG_3596ATPasenr
    Deletions
        ΔrecDMSMEG_1325ExoV, α-subunit2/4
        ΔrecFMSMEG_0003Replication repair protein2/4
        ΔrecGMSMEG_2403ATP-dependent DNA helicase2/2
        ΔrecOMSMEG_4491DNA repair protein1/2
        ΔruvCMSMEG_2943Holliday junction resolvase2/6
        ΔrecRMSMEG_6279Recombination protein4/6
        ΔnusSMSMEG_4923Mismatch repair functionnr
    MSMEG_4922Conserved hypothetical proteinnr
        ΔrhlEMSMEG_1930RNA helicasenr
        ΔdeaDMSMEG_5042deaD RNA helicasenr
    MSMEG_2579Unknownnr
    MSMEG_3027Unknownnr
    MSMEG_4256NLP/P60 family proteinnr
    • ↵a nr, not reported.

  • TABLE 2

    ORBIT-promoted M. tuberculosis modifications

    Rv no.GeneFunction
    Knockouts
        Rv0244cfadE5Probable acyl-CoAa dehydrogenase FadE5
        Rv0248cRv0248cProbable succinate dehydrogenase
        Rv0249cRv0249cProbable succinate dehydrogenase
        Rv0465cRv0465cProbable transcriptional regulatory protein
        Rv0503ccmaA2Cyclopropane-fatty-acyl-phospholipid synthase
        Rv0645cmmaA1Methoxy mycolic acid synthase
        Rv0928pstS3Periplasmic phosphate-binding lipoprotein PstS3
        Rv0929pstC2Phosphate transport integral membrane ABC transporter
        Rv0989cgrcC2Probable polyprenyl-diphosphate synthase
        Rv1161–Rv1164NarG-NarINitrate reduction
        Rv1174cTB8.4Low-molecular-weight T-cell antigen TB8.4
        Rv1184cRv1184cPossible exported protein
        Rv1253deaDProbable cold-shock DeaD-box protein A homolog
        Rv1273cRv1273cProbable drug transport transmembrane ABC transporter
        Rv1321nucSProbable mismatch repair protein
        Rv1488Rv1488Possible exported conserved protein
        Rv1543Rv1543Possible fatty acyl-CoA reductase
        Rv1592Rv1592Conserved hypothetical protein
        Rv1620c–Rv1623ccyd operonRespiratory chain
        Rv1621ccydDTransmembrane ATP-binding protein ABC transporter CydD
        Rv1623ccydAProbable integral membrane cytochrome d ubiquinol oxidase
        Rv1625ccyaadenylate cyclase
        Rv1747Rv1747Probable conserved transmembrane ABC transporter
        Rv1901cinAProbable CinA-like protein CinA
        Rv2047Rv2047Conserved hypothetical protein
        Rv2048cPks12Polyketide synthase
        Rv2383cmbtBPhenyloxazoline synthetase
        Rv2384mbtASalicyl-AMP ligase (SAL-AMP ligase) + salicyl–S-ArCP synthetase
        Rv2563Rv2563Glutamine transport transmembrane protein ABC transporter
        Rv2564Rv2564Glutamine transport ATP-binding protein ABC transporter
        Rv2684arsAProbable arsenic transport integral membrane protein ArsA
        Rv3136PPE51PPE family protein PPE51
        Rv3211rhiEProbable ATP-dependent RNA helicase
        Rv3270ctpCProbable metal cation-transporting P-type ATPase C
        Rv3283sseAProbable thiosulfate sulfurtransferase SseA
        Rv3296lhrProbable ATP-dependent helicase Lhr (large-helicase-related protein)
        Rv3544cfadE28Probable acyl-CoA dehydrogenase
        Rv3574kstRTranscriptional regulatory protein
        Rv3680Rv3680Probable anion transporter ATPase
        Rv3696glpKProbable glycerol kinase
        Rv3822Rv3822Conserved hypothetical protein
        Rv3869eccB1ESX-1 type VII secretion system protein
    Insertions (Flag-Das4 tags)
        Rv0054ssbSingle-strand-binding protein
        Rv0218Rv0218Probable conserved transmembrane protein
        Rv0228Rv0228Probable integral membrane acyltransferase
        Rv0556Rv0556Probable conserved transmembrane protein
        Rv0896gltA2Probable citrate synthase
        Rv0993galUUTP–glucose-1-phosphate uridylyltransferase GalU
        Rv1005cpabBProbable para-aminobenzoate synthase component
        Rv1093glyA1Serine hydroxymethyltransferase
        Rv1392metKProbable S-adenosylmethionine synthetase
        Rv1475cacnProbable iron-regulated aconitate hydratase
        Rv1743pknEProbable transmembrane serine/threonine protein kinase E
        Rv2241aceEPyruvate dehydrogenase E1 component
        Rv2398ccysWProbable sulfate transport membrane protein ABC transporter
        Rv2746cpgsA3Probable PGP synthase PgsA3
        Rv2868cgcpEProbable GcpE protein
        Rv2977cthiLProbable thiamine-monophosphate kinase
        RV2986chupBDNA-binding protein HU homolog
        Rv3034cRv3034cPossible transferase
        Rv3034cRv3034cPossible transferase
        Rv3206cmoeB1Probable molybdenum cofactor biosynthesis protein MoeB1
        Rv3212Conserved alanine-valine-rich protein
        Rv3370cdnaE2DNA polymerase III (alpha chain)
        Rv3410cguaB3Probable inosine-5′-monophosphate dehydrogenase
        Rv3441cmrsAProbable phospho-sugar mutase
        Rv3465rmlCdTDP-4-dehydrorhamnose 3,5-epimerase
        Rv3484cpsAPossible conserved protein CpsA
        Rv3581cispFProbable 2C-methyl-d-erythritol 2,4-cyclodiphosphate synthase
        Rv3663cdppDProbable dipeptide transport ATP-binding protein
        Rv3910Rv3910Probable conserved transmembrane protein
    • ↵a CoA, coenzyme A.

  • TABLE 3

    ORBIT integration plasmidsa

    Plasmid nameType of modificationDrug resistance
    marker
    Addgene ID
    C-terminal tags
        pKM446C-terminal tag: Flag-DAS tagHygr108321
        pKM468C-terminal tag: EGFP-4×Gly-TEV–Flag-6×HisHygr108434
        pKM469C-terminal tag: Venus-4×Gly-TEV–Flag-6×HisHygr108435
        pKM489C terminal tag: SNAP tagHygr108437
        pKM490C-terminal tag: CLIP tagHygr109281
        pKM491C-terminal tag: 4×Gly-TEV–Flag-6×HisHygr109282
        pKM492C-terminal tag: 4×Gly-TEV-Myc-6×HisHygr109283
        pKM493C-terminal tag: TEV–Flag-4×Gly-EGFPHygrIn process
        pKM495C-terminal tag: Flag-DAS tagZeor109284
    Knockouts
        pKM464KnockoutHygr108322
        pKM496KnockoutZeor109301
    Promoter replacements
        pKM464Replacement of endogenous promoter with PHygHygr108322
        pKM496Replacement of endogenous promoter with PGroEL (op-rbs)bZeor109301
        pKM508Replacement of endogenous promoter with P21 (op-rbs)ZeorIn process
        pKM509Replacement of endogenous promoter with P38 (op-rbs)ZeorIn process
    • ↵a All plasmids contain the chloramphenicol resistant cassette (Camr) for use during isolation of the plasmid grown in E. coli. ID, identifier; In process, to be added at a later date.

    • ↵b Optimized ribosome binding site (AGAAAGGAGGAAGGA).

  • TABLE 4

    ORBIT-testing and RecT-Int-expressing plasmids

    PlasmidFunctionsDrug resistanceAddgene ID
    pKM433Phage L5 integrating vector; HygΔ60-bp internal deletion; oriEZeor
    pKM444PTet-Che9c RecT-Bxb1 Int; TetR, oriE, oriMKanr108319
    pKM461PTet-Che9c RecT-Bxb1 Int; SacRB; TetR, oriE, oriMKanr108320
    pKM512PTet-Bxb1 GP47-Int; SacRB; TetR, oriE, oriMZeorIn process

Supplemental Material

  • Figures
  • Tables
  • FIG S1

    Design of the ORBIT oligonucleotide. The Bxb1 attP sequence is placed between the last codon and the stop codon of the M. smegmatis recA gene. The attP site (brown) is flanked by 70 bases of recA C-terminal sequence (blue) and 70 bases of downstream sequence (black), including the recA stop codon (red). Given the rules for selecting the lagging strand for efficient recombineering (see Fig. S4), the reverse complement of the sequence shown here was used as the ORBIT oligonucleotide. Download FIG S1, TIF file, 3.0 MB.

    Copyright © 2018 Murphy et al.

    This content is distributed under the terms of the Creative Commons Attribution 4.0 International license.

  • FIG S2

    ORBIT integrating plasmid pKM446. The integrating pKM446 plasmid contains an attB site, the Flag tag, and the DAS+4 tag. A “CG” base pair is inserted between attB and the Flag tag to ensure that the tags are in frame with the target gene following integration of the plasmid. For this to occur, the ORBIT oligonucleotide has to be designed as described in the Fig. S1 legend. Download FIG S2, TIF file, 1.5 MB.

    Copyright © 2018 Murphy et al.

    This content is distributed under the terms of the Creative Commons Attribution 4.0 International license.

  • FIG S3

    Chromosomal layout of an ORBIT-promoted Flag-DAS+4 fusion. The sequence shown contains the last codon of the target gene (NNN), the 43-bp attL site (orange-brown) created by a crossover between attP and attB (the crossover core sequence is underlined) and a CG base pair (violet), which was included in the ORBIT integrating plasmid to fuse the 43-bp attL site to both the Flag tag (green) and the DAS+4 tag (blue). Finally, a double stop codon for the chromosomal fusion is supplied by the payload plasmid (red). Note that, as required, the attL site lacks a stop codon. Download FIG S3, TIF file, 1.5 MB.

    Copyright © 2018 Murphy et al.

    This content is distributed under the terms of the Creative Commons Attribution 4.0 International license.

  • TABLE S1

    ORBIT oligonucleotides for M. tuberculosis target genes and M. smegmatis target genes. Download Table S1, XLSX file, 0.05 MB.

    Copyright © 2018 Murphy et al.

    This content is distributed under the terms of the Creative Commons Attribution 4.0 International license.

  • FIG S4

    Design of the ORBIT oligonucleotide. To identify the lagging strand from a sequence file of a target gene (reading 5′ to 3′ from the start codon), the attP site is first inserted into the desired position. The ORBIT oligonucleotide sequence will correspond to the top strand if the target gene is transcribed toward the ori sequence (see, e.g., the green arrows) or to the bottom strand if the target gene is transcribed toward the dif region (see, e.g., the red arrows). Download FIG S4, TIF file, 1.5 MB.

    Copyright © 2018 Murphy et al.

    This content is distributed under the terms of the Creative Commons Attribution 4.0 International license.

PreviousNext
Back to top
Download PDF
Citation Tools
ORBIT: a New Paradigm for Genetic Engineering of Mycobacterial Chromosomes
Kenan C. Murphy, Samantha J. Nelson, Subhalaxmi Nambi, Kadamba Papavinasasundaram, Christina E. Baer, Christopher M. Sassetti
mBio Dec 2018, 9 (6) e01467-18; DOI: 10.1128/mBio.01467-18

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this mBio article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
ORBIT: a New Paradigm for Genetic Engineering of Mycobacterial Chromosomes
(Your Name) has forwarded a page to you from mBio
(Your Name) thought you would be interested in this article in mBio.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
ORBIT: a New Paradigm for Genetic Engineering of Mycobacterial Chromosomes
Kenan C. Murphy, Samantha J. Nelson, Subhalaxmi Nambi, Kadamba Papavinasasundaram, Christina E. Baer, Christopher M. Sassetti
mBio Dec 2018, 9 (6) e01467-18; DOI: 10.1128/mBio.01467-18
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • INTRODUCTION
    • RESULTS
    • DISCUSSION
    • MATERIALS AND METHODS
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

Mycobacterium smegmatis
bacteriophage genetics
gene replacement
genetic fusions
metabolic engineering
promoter replacements
recombineering
tuberculosis

Related Articles

Cited By...

About

  • About mBio
  • Editor in Chief
  • Board of Editors
  • AAM Fellows
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Author Warranty
  • Article Types
  • Ethics
  • Contact Us

Follow #mBio

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Online ISSN: 2150-7511